Invesco Nasdaq Biotechnology ETF (IBBQ)
NASDAQ: IBBQ · Real-Time Price · USD
27.58
+0.07 (0.24%)
Nov 12, 2025, 4:00 PM EST - Market closed
IBBQ Holdings Information
IBBQ is an equity ETF with a total of 254 individual holdings. The top holdings are Amgen stock at 7.94%, Vertex Pharmaceuticals at 7.60%, Gilead Sciences at 7.38%, Regeneron Pharmaceuticals at 5.77%, and Alnylam Pharmaceuticals at 4.90%.
Total Holdings
25
Top 10 Percentage
46.91%
Asset Class
Equity
ETF Category
Health
Assets
44.37M
PE Ratio
18.44
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | AMGN | Amgen Inc. | 7.94% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.60% |
| 3 | GILD | Gilead Sciences, Inc. | 7.38% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.77% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.90% |
| 6 | AZN | AstraZeneca PLC | 3.86% |
| 7 | INSM | Insmed Incorporated | 3.46% |
| 8 | ARGX | argenx SE | 2.27% |
| 9 | BIIB | Biogen Inc. | 1.95% |
| 10 | INCY | Incyte Corporation | 1.77% |
| 11 | UTHR | United Therapeutics Corporation | 1.75% |
| 12 | ILMN | Illumina, Inc. | 1.59% |
| 13 | MEDP | Medpace Holdings, Inc. | 1.44% |
| 14 | RPRX | Royalty Pharma plc | 1.42% |
| 15 | NBIX | Neurocrine Biosciences, Inc. | 1.27% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.23% |
| 17 | SMMT | Summit Therapeutics Inc. | 1.16% |
| 18 | SNY | Sanofi | 1.16% |
| 19 | GH | Guardant Health, Inc. | 1.04% |
| 20 | TEM | Tempus AI, Inc. | 1.03% |
| 21 | BBIO | BridgeBio Pharma, Inc. | 1.02% |
| 22 | ASND | Ascendis Pharma A/S | 1.02% |
| 23 | VTRS | Viatris Inc. | 1.01% |
| 24 | RVMD | Revolution Medicines, Inc. | 1.00% |
| 25 | EXEL | Exelixis, Inc. | 0.95% |
As of Nov 10, 2025